Skip to content
Preprint via Europe PMC

A mesoporous oxygen-vacancy-rich ZnO nanoplatform as a catalytic therapeutic hub for osteoarthritis therapy by TRIM15-targeted stem cell rejuvenation

Liu B, Zhang Z, Zhang C, Liu P, Xiong Z, Li Y, Zhang Q, Chen H, Zhang H, Huang C.

· 2026

Abstract

<title>Abstract</title> <p> Osteoarthritis (OA) lacks disease-modifying treatments, partly because aging creates an oxidative-senescent joint niche that accelerates cartilage degeneration and weakens endogenous MSC-mediated repair. We found that aged OA cartilage harboured TRIM15-high MSC-like cells, whereas aged joint-derived MSCs exhibited zinc depletion, defective mitophagy and impaired chondrogenesis. To address these abnormalities, we developed oxygen-vacancy-rich mesoporous ZnO (meso-ZnO <sub>v</sub> ) as an active therapeutic material capable of scavenging reactive oxygen species and restoring zinc homeostasis through Zn <sup>2+</sup> release. Here, we incorporated a Zn <sup>2+</sup> -dependent TRIM15-targeting DNAzyme into meso-ZnO <sub>v</sub> and coated this active core with an ITGA2-enriched hybrid membrane to generate ZDM. ZDM preferentially accumulated in damaged cartilage and enhanced tissue penetration. It alleviated oxidative stress and senescence(definition) and restored cartilage matrix homeostasis, while re-establishing zinc homeostasis and rejuvenating aged MSCs. Mechanistically, ZDM reduced TRIM15 abundance and YAP nuclear localisation and restored SOX9 expression and PINK1-dependent mitophagy, thereby reversing MSC senescence and promoting chondrogenesis. In aged mouse and beagle OA models, ZDM improved joint function, preserved cartilage and subchondral bone, and reduced synovial inflammation. These findings establish a meso-ZnO <sub>v</sub> -based nanotherapeutic strategy that couples microenvironmental restoration with stem-cell rejuvenation, offering a promising disease-modifying approach for age-associated OA. </p>

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
Europe PMC
DOI
10.21203/rs.3.rs-10146539/v1
Canonical
link ↗
Fetched
2026-10-11 MST

Cite this

APA
B, L., Z, Z., C, Z., P, L., Z, X., Y, L., Q, Z., H, C., H, Z., &amp; C., H. (2026). A mesoporous oxygen-vacancy-rich ZnO nanoplatform as a catalytic therapeutic hub for osteoarthritis therapy by TRIM15-targeted stem cell rejuvenation. https://doi.org/10.21203/rs.3.rs-10146539/v1
Vancouver
B L, Z Z, C Z, P L, Z X, Y L, et al. A mesoporous oxygen-vacancy-rich ZnO nanoplatform as a catalytic therapeutic hub for osteoarthritis therapy by TRIM15-targeted stem cell rejuvenation. 2026. doi:10.21203/rs.3.rs-10146539/v1.
BibTeX
@unpublished{liu2026Amesop, title = {A mesoporous oxygen-vacancy-rich ZnO nanoplatform as a catalytic therapeutic hub for osteoarthritis therapy by TRIM15-targeted stem cell rejuvenation}, author = {Liu B and Zhang Z and Zhang C and Liu P and Xiong Z and Li Y and Zhang Q and Chen H and Zhang H and Huang C.}, year = {2026}, doi = {10.21203/rs.3.rs-10146539/v1}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings